Lv1
60 积分 2024-12-06 加入
OA02.06 PSM Analysis Results from REFRACT: A Multi-Center Cohort Study Investigating the Treatment Patterns in EGFR-Mutant Unresectable LA- NSCLC
14小时前
已完结
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
14小时前
已完结
Small cell lung cancer
29天前
已完结
Recent advances in immunotherapy for small cell lung cancer
29天前
已完结
Correction to Lancet Oncol 2017; 18: 812
3个月前
已完结
Cancer incidence and mortality in China, 2022
3个月前
已完结
PL02.11 Normalized Membrane Ratio of TROP2 by Quantitative Continuous Scoring is Predictive of Clinical Outcomes in TROPION-Lung 01
4个月前
已完结
1118P Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study
4个月前
已完结
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
5个月前
已完结
皖公网安备34019202002308
